Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Life-changing results powered by Claya's care and GLP-1 solutions
Recent studies proposed reducing platelet aggregation and arterial thrombosis via targeted suppression of gut microbial proteins associated with TMAO production as a promising therapeutic target (van Mens et al., 2019)
Still, Hims & Hers is losing a potential source of revenue
Sublingual formulations are placed under the tongue rather than swallowed, but they're commonly categorized as "oral" alternatives to injectable medications in consumer search behavior
(Midi does not prescribe this or other unapproved peptides.) What the science says: Theres promising preclinical (aka animal or lab) data on MOTS-c, and early research suggests that MOTS-c may improve metabolism by activating the AMPK pathway and help reverse age-related insulin resistance
